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Response 
To the Editor: 
We appreciate Keshavan et al.‘s interest in our 
article and are intrigued by their failure to replicate 
our findings with regard to the association of post- 
dexamethasone cortisol levels with negative symptom 
severity in medication-free schizophrenic patients. 
Though the samples in both studies appear compa- 
rable (at least 2-weeks medication-free SADSiRDC 
schizophrenic inpatients with roughly equal global 
severity), a closer examination suggests that there 
may have been significant differences between these 
samples: 
The rates of baseline DST nonsuppression noted 
by Keshavan et al. were 11% in contrast to the 
35% noted in our study. The 10 previous inves- 
tigations of DST in medication-free schizophrenic 
patients reported rates of 18%-73%, with half of 
these reporting rates higher than our 35% and the 
other half reporting lower rates. Thus, the rates 
of DST nonsuppression reported by Keshavan et 
al. are very low when compared with previous 
studies, including ours. 
The mean severity of baseline negative symptoms 
as measured by the BPRS was 6.7 2 2.9 in their 
sample as compared to 12.5 I 3.8 in our sample. 
Furthermore, the change in global severity (BPRS 
Total change of 10.7 versus 23.5) and change in 
negative symptoms (BPRS Negative change of 2.3 
versus 5.4) with treatment was significantly lower 
in their sample as compared with ours. All these 
differences are statistically significant at the 5% 
level. 
As their sample differed significantly from ours 
with regard to negative symptom severity and rate3 
of DST nonsuppression, a discrepancy with regard 
to the relationship between these variables could be 
expected. As we had suggested that a common mech- 
anism such as stress/cholinergic excess/?? may un- 
derly both negative symptoms and the increased DST 
nonsuppression in the acute phase of schizophrenia. 
a reduction in the severity of either (or both as in 
Keshavan et al.‘s sample) would obscure this rela- 
tionship by decreasing the signal-to-noise ratio. In- 
cidentally, in a larger sample of 40 medication-free 
schizophrenic inpatients (Mazzara et al. 1989), we 
continue to observe a 35% rate of nonsuppression (14 
of 40) and a relationship between negative symptom 
severity and postdexamethasone cortisol (r = 0.38. 
17 ‘.. 0.02). Though the association is statistically 
signilicant, it is important to note that this relationship 
explains only 14% of the variance. 
‘The frequency and nature of HPA dysregulation 
in schtzophrenia. its relationship with negative symp- 
toms and other aspects of schizophrenic symptoma- 
tology. and the mechanisms underlying this phenom 
enon are unclear, and future studies will hopefully 
shed further light on this important issue. 
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